SCHEMBL29930770

SCHEMBL29930770

Oc1ccc(-c2n[nH]c3ncc(Br)cc23)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 8/20 0.58
DYRK1A Q13627 7/20 0.58
PDPK1 O15530 1/20 0.49
HSP90AB1 P08238 1/20 0.49
FGFR1 P11362 4/20 0.47
FGFR2 P21802 2/20 0.47
FGFR3 P22607 1/20 0.47
MAPK1 P28482 3/20 0.44
MAP2K4 P45985 3/20 0.44
MAPKAPK2 P49137 3/20 0.44
MAPK6 Q16659 3/20 0.44
MAPKAPK3 Q16644 2/20 0.44
MAPKAPK5 Q8IW41 1/20 0.44
CDK2 P24941 3/20 0.40
MAP4K4 O95819 3/20 0.40
CLK2 P49760 3/20 0.40
MAP4K2 Q12851 3/20 0.40
AURKB Q96GD4 3/20 0.40
CLK4 Q9HAZ1 3/20 0.40
PRKD3 O94806 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5061384 0.84 DYRK1A (0.57) DYRK1BDYRK1AFGFR1MAP2K4CDK2
SCHEMBL29930484 0.84 DYRK1B (0.56) DYRK1BDYRK1APDPK1HSP90AB1FGFR1
SCHEMBL28559332 0.83 DYRK1A (0.44) DYRK1BDYRK1AFGFR1MAPK1CDK2
SCHEMBL29930540 0.82 DYRK1B (0.62) DYRK1BDYRK1AFGFR1MAPK1MAP2K4
SCHEMBL28562998 0.81 DYRK1B (0.61) DYRK1BDYRK1AMAPK1SYKGSK3A
SCHEMBL38652158 0.81 AURKA (0.48) DYRK1BDYRK1AFGFR1MAPK1CDK2
SCHEMBL29930747 0.79 DYRK1B (0.67) DYRK1BDYRK1AJAK2CDK5MAPK8
SCHEMBL29930698 0.79 DYRK1A (0.60) DYRK1BDYRK1APDPK1HSP90AB1FGFR1
SCHEMBL29930603 0.79 MAPT (0.46) DYRK1BDYRK1AIDO1TDO2
SCHEMBL38651912 0.78 NCOA1 (0.53) DYRK1BDYRK1AMAPK1CLK4FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO claimed
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed